Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Adynxx eyes an IPO, late-stage program after pain drug clears a PhII hurdle
Adynxx eyes an IPO, late-stage program after pain drug clears a PhII hurdle
Adynxx eyes an IPO, late-stage program after pain drug clears a PhII hurdle
Submitted by
admin
on August 11, 2015 - 6:51pm
Source:
Fierce Biotech
News Tags:
Adynxx
IPOs
painkillers
AYX1
Headline:
Adynxx eyes an IPO, late-stage program after pain drug clears a PhII hurdle
Do Not Allow Advertisers to Use My Personal information
